Menlo Park, California-based Gauss Surgical designed the Triton artificial intelligence-enabled platform for the real-time monitoring of blood loss during surgery. The platform has demonstrated improvements in maternal and surgical care through earlier recognition of hemorrhage leading to earlier intervention, according to a news release.
Kalamazoo, Michigan-based Stryker cited studies that suggest that up to 5% of mothers experience a postpartum hemorrhage, which constitutes the leading cause of maternal death globally, and studies suggest that 70% of those are preventable through monitoring platforms like Triton.
“Gauss Surgical’s innovative Triton technology will help fill the void of quantifying blood loss to enable accuracy, early detection of hemorrhage and prevention of maternal morbidity,” Dylan Crotty, president of Stryker’s Instruments division, said in the release. “Our belief is that Triton technology will help improve the industry standards for quantifying blood loss in the labor and delivery department, furthering Stryker’s commitment to improve safety and outcomes for our caregivers and their patients.”
“Since the advent of modern surgery, visual estimation of blood loss has remained a notoriously inaccurate and imprecise standard of care,” added Gauss Surgical founder and CEO Siddarth Satish. “I am excited to expand this offering with Stryker.”